Parvovirus oncosuppression

Parvoviruses

Volumn , Issue , 2005, Pages 365-378

  Cornelis, Jan J ^a   Deleu, Laurent ^a   Koch, Ute ^a   Rommelaere, J ^a  

^a Cancer Virotherapy Unit   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85145143379     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (104)

1. Anouja, F., Wattiez, R., Mousset, S. and Caillet-Fauquet, P. 1997. The cytotoxicity of the parvovirus minute virus of mice nonstructural protein NS1 is related to changes in the synthesis and phosphorylation of cell proteins. Journal ofVirology 71: 4671-8.
2. Arina, A., Tirapu, I., Alfaro, C. etal. 2002. Clinical implications of antigen transfer mechanisms from malignant to dendritic cells exploiting cross-priming. Experimental Hematology30: 1355-64.
3. Aza-Blanc, P., Cooper, C. L., Wagner, K. et al. 2003. Identification of modulators of TRAIL-induced apoptosis via RNAi-based phenotypic screening. Molecular Cell 12: 627-37.
4. Ball-Goodrich, L. J., Leland, S. E., Johnson, E. A. et al. 1998. Rat parvovirus type 1: the prototype for a new rodent parvovirus serogroup. Journal ofVirology 72: 3289-99.
5. Ball-Goodrich, L. J., Paturzo, F. X., Johnson, E. A. et al. 2002. Immune responses to the major capsid protein during parvovirus infection of rats. Journal ofVirology 76: 10044-9.
6. Bashir, T., Horlein, R., Rommelaere, J. and Willwand, K. 2000. Cyclin A activates the DNA polymerase delta-dependent elongation machinery in vitro: A parvovirus DNA replication model. Proceedings of National Academy of Sciences USA 97: 5522-7.
7. Blachere, N., Li, Z., Chandawarkar, R. Y. et al. 1997. Heat shock protein-peptide complexes reconstituted in vitro, elicited peptide-specific cytotoxic T lymphocyte response and tumor immunity. Journal ofExperimental Medicine 186: 1315-22.
8. Bonnard, G. D., Manders, E. K., Campbell, D. A., Jr. et al. 1976. Immunosuppressive activity of a subline of the mouse EL-4 lymphoma. Evidence for minute virus of mice causing the inhibition. Journal ofExperimental Medicine 143: 187-205.
9. Brown, D. W., Welsh, R. M. and Like, A. A. 1993. Infection of peripancreatic lymph nodes but not islets precedes Kilham rat virus-induced diabetes in BB/Wor rats. Journal ofVirology 67: 5873-8.
10. Brownstein, D. G., Smith, A. L., Jacoby, R. O. et al. 1991. Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Laboratory Investigations 65: 357-64.
11. Brownstein, D. G., Smith, A. L., Johnson, E. A. et al. 1992. The pathogenesis of infection with minute virus of mice depends on expression of the small nonstructural protein NS2 and on the genotype of the allotropic determinants VP1 and VP2. Journal of Virology 66: 3118-24.
12. Caillet-Fauquet, P., Perros, M., Brandenburger, A. et al. 1990. Programmed killing of human cells by means of an inducible clone of parvoviral genes encoding non-structural proteins. Embo Journal 9, 2989-95.
13. Campbell, D. A., Jr., Staal, S. P., Manders, E. K. et al. 1977. Inhibition of in vitro lymphoproliferative responses by in vivo passaged rat 13762 mammary adenocarcinoma cells. II. Evidence that Kilham rat virus is responsible for the inhibitory effect. Cell Immunology 33: 378-91.
14. Chen, Y. Q., de Foresta, F., Hertoghs, J. et al. 1986. Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1. CancerResearch46: 3574-9.
15. Chen, Y. Q., Tuynder, M. C., Cornelis, J. J. et al. 1989. Sensitization of human keratinocytes to killing by parvovirus H-1 takes place during their malignant transformation but does not require them to be tumorigenic. Carcinogenesis 10: 163-7.
16. Chung, Y. H., Jun, H. S., Son, M. et al. 2000. Cellular and molecular mechanism for Kilham rat virus-induced autoimmune diabetes in DR-BB rats. Journal of Immunology 165: 2866-76.
17. Corbau, R., Duverger, V., Rommelaere, J. and Nuesch, J. P. 2000. Regulation of MVM NS1 by protein kinase C: impact of mutagenesis at consensus phosphorylation sites on replicative functions and cytopathic effects. Virology 278: 151-67.
18. Cornelis, J. J., Becquart, P., Duponchel, N. et al. 1988a. Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or simian virus 40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice. Journal ofVirology 62: 1679-86.
19. Cornelis, J. J., Spruyt, N., Spegelaere, P. et al. 1988b. Sensitization of transformed rat fibroblasts to killing by parvovirus minute virus of mice correlates with an increase in viral gene expression. Journal of Virology 62: 3438-44.
20. Daeffler, L., Horlein, R., Rommelaere, J. and Nuesch, J. P. 2003. Modulation of minute virus of mice cytotoxic activities through site-directed mutagenesis within the NS coding region. Journal of Virology 77: 12466-78.
21. Davis, C., Segev-Amzaleg, N., Rotem, I. etal. 2003. The P4 promoter of the parvovirus minute virus of mice is developmentally regulated in transgenic P4-LacZ mice. Virology 306: 268-79.
22. Deleu, L., Fuks, F., Spitkovsky, D. et al. 1998. Opposite transcriptional effects of cyclic AMP-responsive elements in confluent or p27KIP-overexpressing cells versus serum-starved or growing cells. Molecular Cell Biology 18: 409-19.
23. Dudley, M. E., Wunderlich, J. R., Robbins, P. F. et al. 2002. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298: 850-4.
24. Dupressoir, T., Vanacker, J. M., Cornelis, J. J. et al. 1989. Inhibition by parvovirus H-1 of the formation of tumors in nude mice and colonies in vitro by transformed human mammary epithelial cells. Cancer Research 49: 3203-8.
25. Engers, H. D., Louis, J. A., Zubler, R. H. and Hirt, B. 1981. Inhibition of T cell-mediated functions by MVM(i), a parvovirus closely related to minute virus of mice. Journal of Immunology 127: 2280-5.
26. Faisst, S., Guittard, D., Benner, A. et al. 1998. Dose-dependent regression of HeLa cell-derived tumours in SCID mice after parvovirus H-1 infection. International Journal of Cancer 75: 584-9.
27. Fuks, F., Deleu, L., Dinsart, C. et al. 1996. ras oncogene-dependent activation of the P4 promoter of minute virus of mice through a proximal P4 element interacting with the Ets family of transcription factors. Journal ofVirology 70: 1331-9.
28. Gaertner, D. J., Jacoby, R. O., Johnson, E. A. et al. 1995. Persistent rat virus infection in juvenile athymic rats and its modulation by immune serum. Laboratory Animal Science 45: 249-53.
29. Gaertner, D. J., Jacoby, R. O., Johnson, E. A. et al. 1993. Characterization of acute rat parvovirus infection by in situ hybridization. Virus Research 28: 1-18.
30. Gaertner, D. J., Smith, A. L. and Jacoby, R. O. 1996. Efficient induction of persistent and prenatal parvovirus infection in rats. Virus Research 44: 67-78.
31. Giese, N., DeMartino, L., Haag, A. et al. 2000. Autonomous parvovirus- based vectors: potential for gene therapy of cancer. In: G. Gregoriades and B. McCormack (eds), Targeting ofDrugs. Ohmsha: IOS Press, pp. 34-52.
32. Giese, N. A., Raykov, Z., DeMartino, L. et al. 2002. Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice. Cancer Gene Therapy 9, 432-42.
33. Gu, Z., Plaza, S., Perros, M. et al. 1995. NF-Y controls transcription of the minute virus of mice P4 promoter through interaction with an unusual binding site. Journal ofVirology 69: 239-46.
34. Gu, Z., Kuntz-Simon, G., Rommelaere, J. and Cornelis, J. 1999. Oncogenic transformation-dependent expression of a transcription factor NF-Y subunit. Molecular Carcinogenesis 24: 294-9.
35. Guberski, D. L., Thomas, V. A., Shek, W. R. et al. 1991. Induction of type I diabetes by Kilham's rat virus in diabetes-resistant BB/Wor rats. Science 254: 1010-3.
36. Guetta, E., Graziani, Y. and Tal, J. 1986. Suppression of Ehrlich ascites tumors in mice by minute virus of mice. Journal of National Cancer Institute 76: 1177-80.
37. Haag, A., Menten, P., Van Damme, J. et al. 2000. Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice. Human Gene Therapy 11: 597-609.
38. Herrero, Y. C. M., Cornelis, J. J., Herold-Mende, C. et al. 2004. Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing. International Journal of Cancer 109: 76-84.
39. Hirose, S., Wakiya, M., Kawano-Nishi, Y. et al. 1993. Somatic diversification and affinity maturation of IgM and IgG anti-DNA antibodies in murine lupus. European Journal of Immunology 23: 2813-20.
40. Jacoby, R. O., Bhatt, P. N., Gaertner, D. J. et al. 1987. The pathogenesis of rat virus infection in infant and juvenile rats after oronasal inoculation. Archives ofVirology 95: 251-70.
41. Jacoby, R. O., Johnson, E. A., Ball-Goodrich, L. et al. 1995. Characterization of mouse parvovirus infection by in situ hybridization. Journal ofVirology 69: 3915-9.
42. Jacoby, R. O., Ball-Goodrich, L. J., Besselsen, D. G. et al. 1996. Rodent parvovirus infections. Laboratory Animal Science 46: 370-80.
43. Jacoby, R. O., Johnson, E. A., Paturzo, F. X. and Ball-Goodrich, L. 2000. Persistent rat virus infection in smooth muscle of euthymic and athymic rats. Journal ofVirology 74: 11841-8.
44. Janeway, C. A., Jr. and Medzhitov, R. 2002. Innate immune recognition. Annual Review of Immunology 20: 197-216.
45. Juin, P., Hueber, A. O., Littlewood, T. and Evan, G. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Development 13: 1367-81.
46. Kimsey, P. B., Engers, H. D., Hirt, B. and Jongeneel, C. V. 1986. Pathogenicity of fibroblast- and lymphocyte-specific variants of minute virus of mice. Journal ofVirology 59: 8-13.
47. Klefstrom, J., Verschuren, E. W. and Evan, G. 2002. c-Myc augments the apoptotic activity of cytosolic death receptor signaling proteins by engaging the mitochondrial apoptotic pathway. Journal of Biological Chemistry 277: 43224-32.
48. Kuntz-Simon, G., Bashir, T., Rommelaere, J. and Willwand, K. 1999. Neoplastic transformation-associated stimulation of the in vitro resolution of concatemer junction fragments from minute virus of mice DNA. Journal ofVirology 73: 2552-8.
49. Lamana, M. L., Albella, B., Bueren, J. A. and Segovia, J. C. 2001. In vitro and in vivo susceptibility of mouse megakaryocytic progenitors to strain i of parvovirus minute virus of mice. Experimental Hematology 29: 1303-9.
50. Lang, S. 2003. Rekombinante Parvoviren in der Gentherapie von Krebs: Vektorcharakterisierung und Analyse der Wirksamkeit In: Naturwissenschaftlich-Mathematischen Gesamtfakultaet. Ruprecht-Karls Universitaet, Heidelberg.
51. Lang, S., Raykov, Z., Giese, N. et al. 2002. Strong humoral but poor cellular immune response to MVMp in C57BL/6 mice In: IX Parvovirus Workshop, 28-31.8.2002, Bologna, Italia
52. Le Cesne, A., Dupressoir, T., Janin, N. et al. 1993. Intralesional administration of a live virus, parvovirus H-1 (PHV-1) in cancer patients: feasibility study. Proceedings of Annual Meeting of American Society ofClinical Oncology 12: 297.
53. Legendre, D. and Rommelaere, J. 1992. Terminal regions of the NS-1 protein of the parvovirus minute virus of mice are involved in cytotoxicity and promoter trans inhibition. Journal ofVirology 66: 5705-13.
54. Legrand, C., Mousset, S., Salome, N. and Rommelaere, J. 1992. Cooperation of oncogenes in cell transformation and sensitization to killing by the parvovirus minute virus of mice. Journal of General Virology 73: 2003-9.
55. Lopez-Guerrero, J. A., Rayet, B., Tuynder, M. etal. 1997. Constitutive activation of U937 promonocytic cell clones selected for their resistance to parvovirus H-1 infection. Blood 89: 1642-53.
56. McKisic, M. D., Lancki, D. W., Otto, G. et al. 1993. Identification and propagation of a putative immunosuppressive orphan parvovirus in cloned T cells. Journal of Immunology 150: 419-28.
57. McKisic, M. D., Paturzo, F. X., Gaertner, D. J. et al. 1995. A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions. Journal of Immunology 155: 3979-86.
58. McKisic, M. D., Paturzo, F. X. and Smith, A. L. 1996. Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation 61: 292-9.
59. McKisic, M. D., Macy, J. D., Jr., Delano, M. L. et al. 1998. Mouse parvovirus infection potentiates allogeneic skin graft rejection and induces syngeneic graft rejection. Transplantation 65: 1436-46.
60. Malerba, M., Daeffler, L., Rommelaere, J. and Iggo, R. D. 2003. Replicating parvoviruses that target colon cancer cells. Journal of Virology 77: 6683-91.
61. Millar, D. G., Garza, K. M., Odermatt, B. et al. 2003. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Natural Medicine 9: 1469-76.
62. Moehler, M., Zeidler, M., Schede, J. et al. 2003. Oncolytic parvovirus H1 induces release of heat-shock protein HSP72 in susceptible human tumor cells but may not affect primary immune cells. Cancer Gene Therapy 10: 477-80.
63. Mori, S., Wolfinbarger, J. B., Miyazawa, M. and Bloom, M. E. 1991. Replication of Aleutian mink disease parvovirus in lymphoid tissues of adult mink: involvement of follicular dendritic cells and macrophages. Journal of Virology 65: 952-6.
64. Mousset, S. and Rommelaere, J. 1982. Minute virus of mice inhibits cell transformation by simian virus 40. Nature 300: 537-9.
65. Mousset, S., Ouadrhiri, Y., Caillet-Fauquet, P. and Rommelaere, J. 1994. The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression. Journal of Virology 68: 6446-53.
66. Nuesch, J. P., Corbau, R., Tattersall, P. and Rommelaere, J. 1998. Biochemical activities of minute virus of mice nonstructural protein NS1 are modulated in vitro by the phosphorylation state of the polypeptide. Journal of Virology 72: 8002-12.
67. Nuesch, J. P., Dettwiler, S., Corbau, R. and Rommelaere, J. 1998. Replicative functions of minute virus of mice NS1 protein are regulated in vitro by phosphorylation through protein kinase C. Journal of Virology 72: 9966-77.
68. Ohshima, T., Iwama, M., Ueno, Y. et al. 1998. Induction of apoptosis in vitro and in vivo by H-1 parvovirus infection. Journal of General Virology 79: 3067-71.
69. Ohshima, T., Yoshida, E., Nakajima, T. et al. 2001. Effects of interaction between parvovirus minute virus of mice NS1 and coactivator CBP on NS1- and p53-transactivation. International Journal of Molecular Medicine 7: 49-54.
70. Okamoto, M., Murakami, M., Shimizu, A. et al. 1992. A transgenic model of autoimmune hemolytic anemia. Journal ofExperimental Medicine 175: 71-9.
71. Op De Beeck, A. and Caillet-Fauquet, P. 1997. The NS1 protein of the autonomous parvovirus minute virus of mice blocks cellular DNA replication: a consequence of lesions to the chromatin? Journal of Virology 71: 5323-9.
72. Op De Beeck, A., Sobczak-Thepot, J., Sirma, H. et al. 2001. NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1). Journal ofVirology 75: 11071-8.
73. Perros, M., Deleu, L., Vanacker, J. M. et al. 1995. Upstream CREs participate in the basal activity of minute virus of mice promoter P4 and in its stimulation in ras-transformed cells. Journal of Virology 69: 5506-15.
74. Plaza, S., Boullard, A., Pele, D. et al. 1991. Unscheduled DNA synthesis: a quantitative indicator of residual immuno-detectable pyrimidine dimers in human fibroblasts after ultraviolet-B irradiation. Photochemistry and Photobiology 53: 217-27.
75. Raj, K., Ogston, P. and Beard, P. 2001. Virus-mediated killing of cells that lack p53 activity. Nature 412: 914-7.
76. Ran, Z., Rayet, B., Rommelaere, J. and Faisst, S. 1999. Parvovirus H-1-induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Research 65: 161-74.
77. Rayet, B., Lopez-Guerrero, J. A., Rommelaere, J. and Dinsart, C. 1998. Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway. Journal ofVirology 72: 8893-903.
78. Raykov, Z., Balboni, G., Aprahamian, M. and Rommelaere, J. 2004. Carrier cell-mediated delivery of oncolytic parvoviruses for targeting metastases. International Journal of Cancer 109: 742-9.
79. Raykov, Z., Saveleya, L., Balboni, G. et al. 2005. B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression. Journal ofVirology 79: 3517-24.
80. Rommelaere, J. and Cornelis, J. J. 1991. Antineoplastic activity of parvoviruses. Journal ofVirology Methods 33: 233-51.
81. Salome, N., van Hille, B., Duponchel, N. et al. 1990. Sensitization of transformed rat cells to parvovirus MVMp is restricted to specific oncogenes. Oncogene5: 123-30.
82. Segovia, J. C., Bueren, J. A. and Almendral, J. M. 1995. Myeloid depression follows infection of susceptible newborn mice with the parvovirus minute virus of mice (strain i). Journal ofVirology 69: 3229-32.
83. Segovia, J. C., Gallego, J. M., Bueren, J. A. and Almendral, J. M. 1999. Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice. Journal ofVirology 73: 1774-84.
84. Segovia, J. C., Guenechea, G., Gallego, J. M. et al. 2003. Parvovirus infection suppresses long-term repopulating hematopoietic stem cells. Journal ofVirology 77: 8495-503.
85. Sheridan, J. P., Marsters, S. A., Pitti, R. M. et al. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277: 818-21.
86. Siegl, G. 1984. Biology and pathogenicity of autonomous parvoviruses. In: K. Bern (ed.), The Parvoviruses. New York: Plenum Press, pp. 297-362.
87. Sol, N., Le Junter, J., Vassias, I. et al. 1999. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. Journal ofVirology 73: 8762-70.
88. Spegelaere, P., van Hille, B., Spruyt, N. et al. 1991. Initiation of transcription from the minute virus of mice P4 promoter is stimulated in rat cells expressing a c-Ha-ras oncogene. Journal ofVirology 65: 4919-28.
89. Srivastava, P. 2002. Roles of heat-shock proteins in innate and adaptive immunity. National Review of Immunology 2: 185-94.
90. Srivastava, P. K. 2000. Immunotherapy of human cancer: lessons from mice. National Immunology 1: 363-6.
91. Studdert, M. J. 1990. Tissue tropism of parvoviruses. In: P. Tijssen (ed.), Handbookof Parvoviruses, Volume II. Boca Raton: CRC Press, pp. 3-27.
92. Tattersall, P. and Bratton, J. 1983. Reciprocai productive and restrictive virus-cell interactions of immunosuppressive and prototype strains of minute virus of mice. Journal of Virology 46: 944-55.
93. Telerman, A., Tuynder, M., Dupressoir, T. etal. 1993. A model for tumor suppression using H-1 parvovirus. Proceedings of National Academy of Sciences USA 90: 8702-6.
94. Toolan, H. 1990. The rodent parvoviruses. In: P. Tijssen (ed.), Handbook of Parvoviruses, Volume II. Boca Raton: CRC Press, pp. 159-76.
95. Toolan, H. and Ledinko, N. 1965. Growth and cytopathogenicity of H-viruses in human and simian cell cultures. Nature 208: 812-3.
96. Ueno, Y., Harada, T., Iseki, H. et al. 2001. Propagation of rat parvovirus in thymic lymphoma cell line C58(NT)d and subsequent appearance of a resistant cell clone after lytic infection. Journal of Virology 75: 3965-70.
97. van Elsas, A., Hurwitz, A. A. and Allison, J. P. 1999. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)- producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. Journal ofExperimental Medicine 190: 355-66.
98. Van Hille, B., Duponchel, N., Salome, N. et al. 1989. Limitations to the expression of parvoviral nonstructural proteins may determine the extent of sensitization of EJ-ras-transformed rat cells to minute virus of mice. Virology 171: 89-97.
99. Van Pachterbeke, C., Tuynder, M., Brandenburger, A. et al. 1997. Varying sensitivity of human mammary carcinoma cells to the toxic effect of parvovirus H-1. European Journal of Cancer 33: 1648-53.
100. Vanacker, J. M., Laudet, V., Adelmant, G. et al. 1993. Interconnection between thyroid hormone signalling pathways and parvovirus cytotoxic functions. Journal of Virology 67: 7668-72.
101. Ward, S., Casey, D., Labarthe, M. C. et al. 2002. Immunotherapeutic potential of whole tumour cells. Cancer Immunology and Immunotherapy 51: 351-7.
102. Wrzesinski, C., Tesfay, L., Salome, N. et al. 2003. Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells. Journal of Virology 77: 3851-8.
103. Zadori, Z., Szelei, J., Lacoste, M. C. et al. 2001. A viral phospholipase A2 is required for parvovirus infectivity. Developmental Cell 1: 291-302.
104. Zipris, D., Hillebrands, J. L., Welsh, R. M. et al. 2003. Infections that induce autoimmune diabetes in BBDR rats modulate CD4 + CD25+ T cell populations. Journal of Immunology 170: 3592-602.